1 option
Drug compounding for veterinary professionals / Lauren R. Eichstadt Forsythe, Alexandria E. Gochenauer.
- Format:
- Book
- Author/Creator:
- Eichstadt Forsythe, Lauren R., editor.
- Gochenauer, Alexandria E., author.
- Language:
- English
- Subjects (All):
- Veterinary drugs.
- Physical Description:
- 1 online resource
- Place of Publication:
- Hoboken, New Jersey : John Wiley & Sons, Inc., [2023]
- Contents:
- Cover
- Title Page
- Copyright Page
- Contents
- Foreword
- Preface
- List of Acronyms
- About the Companion Website
- Introduction
- Chapter 1 Compounding Regulations
- Organizations and Regulatory Agencies Involved with Compounding
- Food and Drug Administration
- United States Pharmacopeia
- Drug Enforcement Administration
- State Boards of Pharmacy
- State Veterinary Boards
- Compliance Policy Guides and Guidance for Industry Documents
- What Is Compounding?
- The Food, Drug, and Cosmetic Act
- Animal Medicinal Drug Use Clarification Act
- Preparing Compounds from an Approved Product or a Pure Drug Powder
- Federal Versus State Law [8]
- Office Use Compounding
- Drug Quality and Security Act [26]
- Finding Additional Information
- References
- Chapter 2 Risk-Benefit Analysis of Compounded Medications
- Benefits of Compounded Products
- Dosage Form
- Flavoring
- Dosage Strength
- Eliminating Ingredients
- Availability Issues
- Appropriate Use of Compounded Medications
- FDA-Approved Drugs
- Compounded Medication Risks
- Compounded (USP) Versus Manufactured (cGMP)
- Risks Associated with Compounded Medications - A Look at the Literature
- Studies Showing Incorrect Potency
- Studies Showing Lack of Stability
- Studies Showing Lack of Efficacy
- Risks Associated with Specific Types of Compounds
- Active Ingredient Source Decisions
- Patient-Specific Compounding Versus Office Use Compounding
- Adverse Event Reporting
- Identifying Potential Formulation Issues
- Drugs Recalls
- Selecting a Compounding Pharmacy
- Client Education
- Reducing Risk in Practice
- Conclusion
- Chapter 3 Beyond-Use Dating
- Factors Considered When Assigning BUDs and Expiration Dates
- USP Default BUDs
- Stability Studies
- Evaluating Stability Studies
- Determining BUDs for In-House Formulations.
- BUD Considerations When Prescribing Compounded Medications
- Chapter 4 Identifying High-Quality Compounding Pharmacies
- Case Study 1
- Case Study 2
- What to Evaluate
- General Practices
- Staff Skill Level
- Familiarity with Veterinary Medicine
- Pharmacy Culture
- Ways to Evaluate Compounding Pharmacies
- Looking Beyond the Pharmacy's Website
- What to Look for on a Tour
- Questions to Ask the Pharmacist in Charge
- Chapter 5 Formulation Development
- Dosage Forms
- Oral Administration
- Transdermal Administration
- Topical Administration
- Otic Administration
- Other Routes of Administration
- Ingredients
- Organic Salts
- Inorganic Salts
- Oral Liquid Medications
- Oral Solid Medications
- Emulsions
- Transdermal Medications
- Cream, Gel, and Ointment Medications
- Hazardous Drugs
- Beyond-Use Dates
- Formulation Resources
- Calculations
- Measurements Used in Compounding
- Displacement Factor
- Capsules: Packing Statistics
- Packing Statistic of Drug
- Average Weight of Ingredients
- Percentage of Drug per Capsule Using Bulk Powder
- Percentage of Drug per Capsule Using Manufactured Tablet
- Percentage/Amount of Filler per Capsule
- Conversion to Grams
- Compounding Formulations to Avoid
- Formulation Development Process
- Developing a Compounding Formula: Example 1 (USP Compounding Compendium)
- Developing a Compounding Formula: Example 2 (Stability-Indicating Assay)
- Compounding Formulation Assessment
- Chapter 6 Compounding in House
- Documentation
- Master Formulation Record
- Compounding Record
- Formulation Record Components
- Quality Assurance and Quality Control
- Labeling
- Packaging and Storage
- Compounding Techniques
- Trituration
- Sifting
- Geometric Dilution
- Wetting
- Colored Tracers
- Equipment.
- Mortars and Pestles
- Glassware
- Containers
- Scales
- Spatulas and Measuring Devices
- Equipment Cleaning
- Training
- Formulation Instructions
- Species-Specific Information
- Toxicities
- Potency Designations
- Feasibility for a Veterinary Clinic
- Index
- EULA.
- Notes:
- Electronic reproduction. Hoboken, N.J. Available via World Wide Web.
- Description based on online resource; title from digital title page (viewed on June 28, 2023).
- Local Notes:
- Acquired for the Penn Libraries with assistance from the Clarence J. Marshall Memorial Library Fund.
- Other Format:
- Print version:
- ISBN:
- 9781119764991
- 1119764998
- 9781119764977
- 1119764971
- Publisher Number:
- 99995321502
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.